The assessment available on Thrive Pulse website does not create a doctor-patient relationship. Clinical services are provided by OpenLoop Health and other networks of U.S.-licensed clinicians who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through Thrive Pulse are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. Thrive Pulse does not manufacture compounded medications, and product appearance may differ from website images. Thrive Pulse partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the Thrive Pulse program. Zepbound® is FDA-approved for chronic weight management; Ozempic® is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect Thrive Pulse patient experiences rather than public clinical studies.
Compounded drug products are not FDA approved. FDA does not evaluate compounded products for safety, effectiveness, or quality. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. Not available in all 50 states. Please visit our website for full details, applicable restrictions, and important drug safety information.
Results are not guaranteed and may vary by individual as part of a personalized weight loss and health program.
Copyright 2026 Thrive Pulse. All rights reserved.
